BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fatma H, Siddique HR. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer. Expert Rev Anticancer Ther 2021;21:853-64. [PMID: 33832395 DOI: 10.1080/14737140.2021.1915137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu H, Xiao H, Lu G, Fang S, Akhlaq M. Effect of Transdermal Fentanyl Patch Combined with Enhanced Recovery after Surgery on the Curative Effect and Analgesic Effect of Liver Cancer. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/9722458] [Reference Citation Analysis]
2 Yan Q, Fang X, Li C, Lan P, Guan X. Oncofetal proteins and cancer stem cells. Essays in Biochemistry 2022. [DOI: 10.1042/ebc20220025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Singh D, Afsar Khan M, Siddique HR. Specific Targeting of Cancer Stem Cells by Immunotherapy: A Possible Stratagem to Restrain Cancer Recurrence and Metastasis. Biochem Pharmacol 2022;:114955. [PMID: 35181312 DOI: 10.1016/j.bcp.2022.114955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Vatsa P, Jahan S, Ansari UA, Khan A, Mir SA, Alshehri B, Choudhary RK, Siddiqui AJ. Stem Cell Safety and Sterility Testing: A Promising Approach in Regenerative Medicine. Stem Cell Production 2022. [DOI: 10.1007/978-981-16-7589-8_9] [Reference Citation Analysis]
5 Hu Y, Zai H, Jiang W, Yao Y, Ou Z, Zhu Q. miR-126 in Extracellular Vesicles Derived from Hepatoblastoma Cells Promotes the Tumorigenesis of Hepatoblastoma through Inducing the Differentiation of BMSCs into Cancer Stem Cells. J Immunol Res 2021;2021:6744715. [PMID: 34746322 DOI: 10.1155/2021/6744715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fatma H, Siddique HR, Maurya SK. The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers. Epigenomics 2021;13:1885-900. [PMID: 34693722 DOI: 10.2217/epi-2021-0228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]